Skip to content
KMC Speciality Hospitals logo

KMC Speciality Hospitals

KMCSHIL NSE
₹149.61 down 0.75 (0.50%)
Market Cap
₹2,440 Cr
P/E
43.75

KMC Speciality Hospitals (KMCSHIL) share price was ₹150.36 at the 28 Oct 2026 close; market capitalisation ₹2,452 Cr; P/E (TTM) 43.96; sector Healthcare Services. The share price rose 117.0% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 37.8% year on year to ₹91.8 Cr and net profit was ₹17 Cr, against ₹8 Cr a year earlier (compared with Jun 2025). Promoters held 75.00% of KMC Speciality Hospitals in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 64/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹150.36 +79.79 +113.07% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹2,440 Cr
P/E (TTM)
43.75
EBITDA
₹93.00 Cr
Return on Equity
22.21%
Debt to Equity
0.4
Book Value
₹12.90
EPS (TTM)
₹3.42
52W High
₹185.50
52W Low
₹68.50

Price-based figures as of 29 Oct 2026, 10:45 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Healthcare Services › Hospitals › Hospital

Apollo Hospitals
₹8,232.5056.651,18,371 Cr12.490.26%20.08%19.79%26,675 Cr2,171 Cr
Manipal Health Enterprises
₹638.5585.1483,993 Cr5.110.00%10.42%9.50%11,400 Cr906 Cr
Max Healthcare Institute
₹860.4057.4483,744 Cr7.790.24%13.42%12.70%8,879 Cr1,457 Cr
Aster DM Healthcare
₹677.30110.1359,038 Cr14.030.45%8.84%9.71%5,006 Cr363 Cr
Fortis Healthcare
₹758.8054.6757,286 Cr5.790.14%10.47%12.13%9,607 Cr1,070 Cr
Global Health
₹1,301.6062.9134,996 Cr8.830.04%13.91%15.05%4,800 Cr552 Cr
Narayana Hrudayalaya
₹1,710.0042.8134,946 Cr7.700.26%17.85%11.39%9,185 Cr816 Cr
KMC Speciality Hospitals (this company)
₹149.6143.752,440 Cr11.600.00%22.21%24.64%337 Cr57 Cr
Median 8 companies₹809.6057.0558,162 Cr8.310.19%13.67%12.42%9,032 Cr861 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

64 Good
Overall score

Data confidence 100/100

Category scores

Quality Strong 83
Returns, margins, earnings quality 22% weight
Valuation Poor 37
Cheap vs sector & own history 24% weight
Growth Strong 95
Sales & profit trajectory 9% weight
Financial Health Good 65
Solvency, leverage, coverage 9% weight
Momentum Strong 85
Trend strength, vol-adjusted 12% weight
Ownership Average 49
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 29.6% CAGR over last 5 years
  • Company's median sales growth is 22.9% of last 10 years

Weaknesses

2
  • Stock is trading at 13.1 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
6
Bullish
1

Overall

Bearish

Bearish
7
Neutral
6
Bullish
6

Moving Averages

Neutral

Bearish
5
Neutral
0
Bullish
5

Growth Rate

Revenue Growth
32.42% higher than 3Y

change over 1 year

Net Income Growth
118% higher than 3Y

change over 1 year

Cash Flow Change
37.37%

change over 1 year

EBITDA Margin Change
17.1%

change over 1 year Operating margin 31% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
41
42
49
45
53
56
61
61
67
75
82
82
92
Expenses
31
31
35
33
40
44
45
46
50
54
57
56
63
Operating Profit
10
11
14
12
13
13
16
15
16
21
25
26
28
OPM %
25%
26%
29%
26%
24%
22%
26%
25%
25%
28%
30%
31%
31%
Other Income
2
1
1
1
1
0
1
1
1
1
1
2
2
Interest
0
0
0
0
2
3
2
2
2
2
2
2
2
Depreciation
2
2
2
3
4
5
5
5
5
5
5
6
6
PBT
9
9
12
9
7
5
10
9
10
15
18
20
22
Tax %
26%
26%
24%
25%
26%
27%
25%
49%
25%
26%
26%
26%
26%
Net Profit
7
7
9
7
6
4
8
5
8
11
14
15
17
EPS (₹)
0.43
0.42
0.58
0.43
0.34
0.24
0.46
0.28
0.46
0.66
0.84
0.9
1.02
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
36
43
55
71
82
96
103
136
156
177
232
306
331
Expenses
31
35
42
56
66
75
79
99
114
129
174
217
231
Operating Profit
6
8
12
14
16
21
23
37
42
48
57
88
100
OPM %
16%
19%
23%
20%
20%
22%
23%
28%
27%
27%
25%
29%
30%
Other Income
0
1
0
0
2
1
2
2
3
4
3
5
6
Interest
2
2
1
1
1
1
1
1
1
2
10
9
8
Depreciation
4
3
3
4
4
5
6
7
8
9
19
22
22
PBT
0
4
8
10
12
17
18
32
36
41
32
63
75
Tax %
0%
21%
33%
32%
30%
30%
29%
26%
26%
25%
32%
26%
—
Net Profit
0
3
5
7
9
12
13
24
27
30
21
47
56
EPS (₹)
0.01
0.2
0.33
0.41
0.53
0.72
0.78
1.46
1.64
1.86
1.31
2.87
3.42
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
16
16
16
16
16
16
16
16
16
16
16
16
Reserves
-6
-3
8
14
23
34
47
70
97
127
148
194
Borrowings
14
10
6
15
10
9
29
29
50
82
89
84
Other Liabilities
7
6
8
8
10
11
13
13
18
38
32
38
Total Liabilities
31
29
38
53
60
70
105
129
182
264
286
332
Fixed Assets
25
23
24
37
36
39
74
75
84
206
248
248
CWIP
0
0
0
0
0
0
2
6
34
1
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
6
7
14
16
24
31
29
48
63
57
38
84
Total Assets
31
29
38
53
60
70
105
129
182
264
286
332
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
5
6
10
12
16
11
26
29
32
38
58
79
Investing
-1
-1
-4
-19
-9
-8
-43
-29
-48
-56
-51
-17
Financing
-5
-5
-5
6
-5
-4
18
-1
16
20
-2
-21
Net Cash Flow
0
0
1
-1
1
-1
1
0
0
3
4
41
Free Cash Flow
5
5
6
-3
13
7
-15
16
-12
-37
-6
63
CFO/OP
112
91
94
100
113
66
120
102
100
101
112
99
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
12
13
12
13
8
8
9
10
10
9
9
9
Inventory Days
42
32
28
24
29
59
39
33
36
31
38
31
Days Payable
169
158
134
143
161
115
117
96
102
113
153
82
Cash Conversion Cycle
-115
-112
-94
-107
-125
-48
-68
-53
-56
-73
-105
-42
Working Capital Days
-70
-60
-46
-37
-28
-18
-15
-27
-22
-73
-22
-19
ROCE %
8%
24%
35%
29%
29%
33%
25%
32%
27%
22%
17%
26%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view KMC Speciality Hospitals insights

63 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

FIIs0.02%Promot.75.00%Others2.95%Public22.03%As ofSep 2026

Documents

1
Concall - Aug 2026 Aug 2026
2
Concall - Jun 2026 Jun 2026
3
Concall - Mar 2026 Mar 2026
4
Concall - Nov 2025 Nov 2025
5
Concall - Sep 2025 Sep 2025

Frequently Asked Questions about KMC Speciality Hospitals

What does KMC Speciality Hospitals (India) Ltd do?
Incorporated in 1982, KMC Speciality Hospitals (India) is in the healthcare sector running, operating, maintaining multi-specialty hospital in Trichy. The company belongs to the Kauvery Hospitals group. The Company is primarily engaged in the business of rendering medical and healthcare services.
Where is KMC Speciality Hospitals (India) Ltd (KMCSHIL) listed?
KMC Speciality Hospitals (India) Ltd trades as KMCSHIL on the NSE and under code 524520 on the BSE.
Which sector does KMC Speciality Hospitals (India) Ltd belong to?
KMC Speciality Hospitals (India) Ltd is classified under the Healthcare Services sector, in the Hospitals industry.
What is the market capitalisation of KMC Speciality Hospitals (India) Ltd?
KMC Speciality Hospitals (India) Ltd has a market capitalisation of ₹2,440 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of KMC Speciality Hospitals (India) Ltd?
KMC Speciality Hospitals (India) Ltd trades at a PE ratio of 43.75 as of 29 Oct 2026, on earnings per share of ₹3.42, against a book value of ₹12.9 per share.
What is the 52-week high and low of KMC Speciality Hospitals (India) Ltd?
Over the last 52 weeks KMC Speciality Hospitals (India) Ltd has traded between ₹68.5 and ₹185.5 as of 29 Oct 2026.
What is the Return on Equity (ROE) of KMC Speciality Hospitals (India) Ltd?
KMC Speciality Hospitals (India) Ltd reported a return on equity of 22.21%. Its debt-to-equity ratio is 0.40.

Company Information

Incorporated in 1982, KMC Speciality Hospitals (India) is in the healthcare sector running, operating, maintaining multi-specialty hospital in Trichy. The company belongs to the Kauvery Hospitals group. The Company is primarily engaged in the business of rendering medical and healthcare services.

Website kauveryhospital.com
Listed 2026-08-17
Face Value ₹ 1
Shares Outstanding 16,30,85,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524520.md for KMC Speciality Hospitals (India) Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month